97 filings
Page 5 of 5
6-K
v4p6dn54iv7gs1j
7 Aug 18
Current report (foreign)
6:35am
6-K
cvgxd5r1azs uy
28 Jun 18
6-K Egm Notice
11:27am
6-K
07mdus4ll l4bll1am9y
4 Jun 18
Current report (foreign)
12:00am
6-K
hrudt4hampl9q4fl11
8 May 18
Announced positive top-line data from two Phase 2 clinical trials ahead of schedule
6:10am
6-K
0dzpz95th5kb6hqxmbxs
4 May 18
Current report (foreign)
11:18am
6-K
5qkzh bhcp4c6ig
4 May 18
Current report (foreign)
11:08am
6-K
6hj6w
18 Apr 18
Current report (foreign)
12:00am
6-K
qqmw0uxmkmaw32an
29 Mar 18
Current report (foreign)
12:00am
6-K
5me5vo0x 12jbv1
22 Mar 18
Current report (foreign)
12:00am
6-K
kz69uiv2fn
9 Nov 17
Emerging clinical data confirms the potential for RPL554 to be an important, novel treatment for patients with COPD
12:00am
6-K
qfxr8qo tqquq8hm
21 Sep 17
Current report (foreign)
12:00am
6-K
333rp4 uda
12 Sep 17
Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium
12:00am
6-K
glj5v 69rgfzseamie02
24 Aug 17
Current report (foreign)
12:00am
6-K
6k991p
8 Aug 17
Current report (foreign)
12:00am
6-K
o4lm63b
26 May 17
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
12:00am
6-K
5tv3o0l9kyv4vpzu1
18 May 17
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
12:00am
6-K
6t58b k1rmc0
3 May 17
Verona Pharma Announces Director Purchases and Related Party Transactions
12:00am